Literature DB >> 15580315

[III Guidelines on the treatment of myocardial acute infarction].

.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15580315     DOI： /S0066-782X2004002200001

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  5 in total

1.  Effect of beta-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction.

Authors:  Antonio Eduardo Pesaro; Alexandre de Matos Soeiro; Carlos Vicente Serrano; Roberto Rocha Giraldez; Renata Teixeira Ladeira; José Carlos Nicolau
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

2.  Quality and effectiveness of different approaches to primary care delivery in Brazil.

Authors:  Erno Harzheim; Bruce B Duncan; Airton T Stein; Carlo R H Cunha; Marcelo R Goncalves; Thiago G Trindade; Mônica M C Oliveira; Maria Eugênia B Pinto
Journal:  BMC Health Serv Res       Date:  2006-12-05       Impact factor: 2.655

3.  Case 02/2015 - A 67 Year-Old Woman with Sudden Cardiogenic Shock in the 7th Day after Acute Myocardial Infarction.

Authors:  Bruno Aguiar Pinheiro; Alice Tatsuko Yamada; Vera Demarchi Aiello
Journal:  Arq Bras Cardiol       Date:  2015-07-01       Impact factor: 2.000

4.  Quality of life of patients after an acute coronary event: hospital discharge.

Authors:  Cristiane Maria Carvalho Costa Dias; Luciana Bilitario Macedo; Lilian Tapioca Jones Cunha Gomes; Paula Luzia Seixas Pereira de Oliveira; Iana Verena Santana Albuquerque; Amanda Queiroz Lemos; Cristina Aires Brasil; Eloisa Pires Ferreira Prado; Pedro Santiago Macedo; Francisco Tiago Oliveira de Oliveira; Helena Franca Correia Dos Reis; Eduardo Sahade Darze; Armenio Costa Guimaraes
Journal:  J Clin Med Res       Date:  2014-07-28

5.  Digital Health, Universal Right, Duty of the State?

Authors:  Marcelo Antônio Cartaxo Queiroga Lopes; Gláucia Maria Moraes de Oliveira; Luciano Mariz Maia
Journal:  Arq Bras Cardiol       Date:  2019-08-29       Impact factor: 2.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.